Key Metrics
CiteScore 

8
SJR 

Q2Virology

SNIP 

1.21
Recommended pre-submission checks
Powered by 

Topics Covered on Antiviral Chemistry and Chemotherapy
Antiviral Chemistry and Chemotherapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | USD 1500 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | International Society of Antiviral Research |
| Frequency | Bi-monthly |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Antiviral Chemistry and Chemotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Antiviral Chemistry and Chemotherapy
The development of BVDU: An odyssey
- 1 Jan 2023
- Antiviral Chemistry & Chemotherapy
The continuing need for therapeutic agents for respiratory syncytial virus infection
- 1 Jan 2023
- Antiviral Chemistry & Chemotherapy
Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens.
- 1 Jan 2022
- Antiviral chemistry & chemotherapy
Reflections on the Rega Institute for Medical Research, at the fiftieth anniversary of the Rega Stichting vzw (Rega Instituut vzw, Rega Foundation)
- 1 Jan 2022
- Antiviral Chemistry & Chemotherapy
Meeting report: 34th international conference on antiviralresearch
- 1 Jan 2022
- Antiviral Chemistry & Chemotherapy
Activity of 3,19-isopropylidinyl andrographolide against herpes simplex virus type 1 in an animal model
- 1 Jan 2022
- Antiviral Chemistry & Chemotherapy
The development of BVDU: An odyssey
- 1 Jan 2023
- Antiviral Chemistry & Chemotherapy
The continuing need for therapeutic agents for respiratory syncytial virus infection
- 1 Jan 2023
- Antiviral Chemistry & Chemotherapy
Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens.
- 1 Jan 2022
- Antiviral chemistry & chemotherapy
Reflections on the Rega Institute for Medical Research, at the fiftieth anniversary of the Rega Stichting vzw (Rega Instituut vzw, Rega Foundation)
- 1 Jan 2022
- Antiviral Chemistry & Chemotherapy
Meeting report: 34th international conference on antiviralresearch
- 1 Jan 2022
- Antiviral Chemistry & Chemotherapy
Activity of 3,19-isopropylidinyl andrographolide against herpes simplex virus type 1 in an animal model
- 1 Jan 2022
- Antiviral Chemistry & Chemotherapy
FAQs on Antiviral Chemistry and Chemotherapy
What is the publishing frequency of Antiviral Chemistry and Chemotherapy? 
How many articles did Antiviral Chemistry and Chemotherapy publish last year? 
What is the eISSN & pISSN for Antiviral Chemistry and Chemotherapy? 
What is Citescore for Antiviral Chemistry and Chemotherapy? 
What is SNIP score for Antiviral Chemistry and Chemotherapy? 
What is the SJR for Antiviral Chemistry and Chemotherapy? 
Who is the publisher of Antiviral Chemistry and Chemotherapy? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary